Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series-Reference-Cited by-同舟云学术

Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series

Published:2019-12-14 Issue:2 Volume:146 Page:449-455
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Oing Christoph^ORCID,Hentrich Marcus,Lorch Anja,Gläser Dietrich,Rumpold Holger,Ochsenreither Sebastian,Richter Stephan,Dieing Annette,Zschäbitz Stefanie,Pereira Ronnie Rodrigues,Bokemeyer Carsten,Seidel Christoph

Funder

European Society for Medical Oncology

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-019-03071-2.pdf

Reference7 articles.

1. Albers P et al (2015) Guidelines on testicular cancer: 2015 update. Eur Urol. https://doi.org/10.1016/j.eururo.2015.07.044

2. Bokemeyer C, Oechsle K, Honecker F, Mayer F, Hartmann JT, Waller CF, Böhlke I, Kollmannsberger C; German Testicular Cancer Study Group (2008) Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group. Ann Oncol 19(3):448–453

3. Gerwing M et al (2016) Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells. J Cancer Res Clin Oncol 142:1979–1994

4. International Prognostic Factors Study G et al (2010) Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906–4911. https://doi.org/10.1200/jco.2009.26.8128

5. Oing C, Kollmannsberger C, Oechsle K, Bokemeyer C (2016) Investigational targeted therapies for the treatment of testicular germ cell tumors. Expert Opin Investig Drugs 25:1033–1043. https://doi.org/10.1080/13543784.2016.1195808

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients;International Journal of Molecular Sciences;2023-04-26

2. Overcoming Chemotherapy Resistance in Germ Cell Tumors;Biomedicines;2022-04-22

3. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care;Frontiers in Cell and Developmental Biology;2022-04-08

4. Emerging nanotaxanes for cancer therapy;Biomaterials;2021-05

5. Salvage management of patients with relapsing testicular germ cell tumors;Current Opinion in Urology;2021-03-17